EMAIL THIS PAGE TO A FRIEND

Journal of medicinal chemistry

Function-oriented biosynthesis of beta-lactone proteasome inhibitors in Salinispora tropica.


PMID 19746976

Abstract

The natural proteasome inhibitor salinosporamide A from the marine bacterium Salinispora tropica is a promising drug candidate for the treatment of multiple myeloma and mantle cell lymphoma. Using a comprehensive approach that combined chemical synthesis with metabolic engineering, we generated a series of salinosporamide analogues with altered proteasome binding affinity. One of the engineered compounds is equipotent to salinosporamide A in inhibition of the chymotrypsin-like activity of the proteasome yet exhibits superior activity in the cell-based HCT-116 assay.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

441171
(Bromomethyl)cyclobutane, 97%
C5H9Br